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Notch signalsmediate awide range of activities in development and cancer. A report in this issue ofCell Stem
Cell (Bouras et al., 2008) demonstrates that Notch serves as a switch that controls cell fate and tissue homeo-
stasis in mammary epithelium.A number of studies have shown that
overexpression of Notch causes mam-
mary tumors in mouse models (Wu et al.,
2007). Aberrant Notch signaling is also
detected in human breast cancers (Stylia-
nou et al., 2006). In addition, inhibition of
Notch signaling in the mouse mammary
gland leads to an imbalance of basal
and luminal cells (Buono et al., 2006), sug-
gesting that Notch signals regulate epi-
thelial cell fate and may impact stem cell
activity. In order to gain insight into the
population-specific roles of Notch sig-
nals, Visvader and colleagues (Bouras
et al., 2008) manipulated Notch pathway
activation in defined epithelial cell sub-
populations. The authors employed retro-
viral vectors that either attenuated or con-
stitutively activated Notch signaling and
assayed for functional impact in short-
term cultures as well as transplantation
models.
The mammary gland consists of a sys-
tem of ducts, which are composed of
two major cell types: luminal cells, which
line the ducts and alveoli, and an outer
network of contractile basal or myoepi-
thelial cells. The epithelium undergoes
dramatic changes during pregnancy to
generate milk-producing alveolar struc-
tures. The majority of epithelial cells
regresses at the end of lactation, to be re-
stored in subsequent pregnancies, illus-
trating a large capacity for regeneration
and self-renewal. Previous studies have
established that small pieces of epithe-
lium can redevelop an entire mammary
gland from stem cells that are dispersed
at discrete locations along the ductal
tree. This trait forms the basis for valuable
transplantation assays used to determine
the functional properties of purified and/or
modified epithelial cell populations, as
discussed below.In recent years, three distinct fractions
of epithelial cells have been isolated that
reflect a hierarchical relationship within
themammary gland (Figure 1A). One pop-
ulation is able to regenerate an entire duc-
tal system upon transplantation and is
considered to be highly enriched in stem
cells. However, cells in this fraction also
express the transcription factor p63,
cytokeratin 5, and smooth muscle actin,
all characteristic of mature myoepithelial
cells. The other two fractions both ex-
press luminal-type cytokeratins. One
population, termed mammary colony-
forming cells, represents a progenitor
subset, based on the ability to form milk-
producing colonies when grown in three-
dimensional culture. The final fraction of
cells contains more mature, differentiated
luminal cells and does not form out-
growths or colonies (Shackleton et al.,
2006; Stingl et al., 2006).
The Notch pathway is initiated when
two sets of transmembrane proteins
(Notch receptors and Delta or Jagged
family ligands) bind and activate a tran-
scription complex that contains the
cleaved Notch intracellular domain
(NICD) and CBF-1 (also known as Igkjrb,
RBP-Jk, Rbpsuh). The close-range re-
ceptor-ligand relationship mediates sig-
nals between neighboring cells and has
been demonstrated to impact cell lineage
decisions, particularly in the central ner-
vous system, the hematopoietic system,
intestine, and skin. Expression analyses
performed by Bouras et al. (2008) re-
vealed varying levels of Notch ligands, re-
ceptors, and target genes present in the
different mammary cell fractions. Even
though target genes were most abundant
in the mature subset, subtle differences in
the levels of specific pathway compo-
nents in each fraction probably reflectCell Stem Cella complex regulation of Notch activities.
Differential expression of Notch pathway
members was also observed in transcrip-
tome analyses of human mammary cell
populations (Raouf et al., 2008).
In order to dissect the specific impact of
Notch signaling in the mammary lineage,
the stem cell-containing population was
infected with retroviral vectors expressing
CBF-1 shRNA. The resulting inhibition of
Notch signaling led to a slight increase
in stem cell activity and increased clono-
genic activity (Bouras et al., 2008)
(Figure 1B). In addition, in vitro cultured
cells formed larger, more numerous colo-
nies, which displayed a basal phenotype
andwere devoid of luminal markers. Inter-
estingly, the center of these cultures con-
tained concentrically layered material
reminiscent of keratinized epidermal
cysts, like those observed when Cbf-1
was deleted in basal cells of the epidermis
(Yamamoto et al., 2003). Currently, the
classification of the cysts is based solely
on morphological criteria and remains to
be substantiated by staining of epidermal
markers. Nonetheless, the altered nature
of these colonies shows a profound effect
on the identity of the Notch-inhibited cells
and may even indicate a switch to an epi-
dermal fate.
The ability to isolate specific cell popu-
lations and manipulate them with viral
vectors permits a deconstructive ap-
proach to study genes that regulate the
stem cell function. Indeed, the control of
cell lineage decisions at both the stem
and progenitor cell levels can be assayed
in short-term cultures. This experimental
system also offers a ‘‘shortcut’’ relative
to the generation of transgenic animals
(Welm et al., 2008). Yet, there are some
caveats: first, targeting of the cells has
to be efficient and specific, a drawback3, October 9, 2008 ª2008 Elsevier Inc. 359
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well. Furthermore, though of great
value to assay immediate effects,
three-dimensional culture cannot com-
pletely recapitulate the physiological
conditions present in an intact animal.
However, use of the transplantation
assay to transfer test populations into
fat pads of recipients allows the as-
sessment of their functional capacity
to generate ductal outgrowths and
terminal differentiation in a pregnant
host. Finally, one must not forget that
some aspects of the mutual interac-
tions between different cell lineages
are lost if cell fractions are analyzed in
isolation.
Indeed, the use of different assay
systems can lead to a range of results
that may seem conflicting. For exam-
ple, an opposite role for Notch in
mammary stem cell function has
been observed (Dontu et al., 2004).
Using an in vitro human mammo-
sphere culture system to assess stem
cell activity and lineage commitment,
the authors concluded that activation
of the Notch pathway positively regu-
lated stem cell activity and basal cell
expansion. Yet the findings by Bouras
et al. described above are in agree-
ment with the observations reported by
Buono et al. (2006), who used a Cre re-
combinase-based genetic method to de-
lete Cbf-1 and disrupt Notch signaling.
These authors found progressive expan-
sion of the basal cell population, particu-
larly during the course of pregnancy. This
outcome appeared to be due to in-
creased proliferation of basal cells, com-
bined with a luminal-to-basal fate switch,
based on the presence of cells displaying
a mixed phenotype, i.e., simultaneous
expression of luminal cytokeratins and
the basal marker p63. In the gene dele-
tion experiment, Notch signaling was in-
hibited in both the basal and luminal pro-
genitor cell populations in situ (Buono
et al., 2006), whereas Dontu et al. and
Bouras et al. examined the impact of
Notch signal disruption within isolated
stem cell fractions. The varying results
across systems most likely can be as-
cribed to intraepithelial regulatory inter-
actions between basal and luminal cells,360 Cell Stem Cell 3, October 9, 2008 ª200and they highlight the importance of con-
sidering the context in which stem cell
function is assayed.
In addition to loss-of-function experi-
ments, Visvader and colleagues also ma-
nipulated Notch signals to achieve hyper-
stimulation of the pathway (Figure 1C)
(Bouras et al., 2008). In doing so, tar-
geted stem cells gave rise to larger colo-
nies of exclusively luminal cells in culture
(Figure 1). Outgrowths in transplanted
hosts formed hyperplastic nodules that
also expressed luminal markers. Remark-
ably, enhancing Notch activity also en-
dowed the luminal precursor cell pool
with the potential to generate hyper-
plastic structures, an activity normally
restricted to the more primitive, stem-
cell-containing population. In vitro, the
targeted progenitor cells formed anchor-
age-independent spheres. Combined,
these observations suggest that Notch
can target stem cells as well as progeni-
tors for transformation, indicating that
Figure 1. Notch Regulates Cell Fate in
Mammary Epithelium
(A) Stem cells give rise to stem cells and multipotent
progenitors, which then develop along either the lumi-
nal or myoepithelial (basal) lineage. Notch signals ap-
pear to be involved in signaling within and between
the different cell types.
(B) Reduction of Notch signals in stem cells promotes
generation of stem cells and preferential differentiation
toward the myoepithelial cell fate.
(C) Directing constitutive Notch activation to stem cells
or progenitor cells results in increased stem cell activity
and transformation of cells in the luminal lineage.8 Elsevier Inc.both populations may be considered
therapeutic targets.
The next challenge will be to dissect
cell- and stage-specific actions of dis-
tinct Notch ligand and receptor interac-
tions, or critical downstream target
genes, in defined cell lineages. Once
identified, each candidate can be as-
sayed in three-dimensional cultures or
transplantation of mixtures of individu-
ally manipulated cell fractions to under-
stand and possibly revert transformed
cells. Together, these approaches
should also help generate models to di-
rect differentiation toward a desired lin-
eage in the mammary gland as well as
other tissues.
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